The Pharmacological Mechanisms of Xiaochaihutang in Treating Breast Cancer Based on Network Pharmacology

被引:6
|
作者
Zheng, Lin [1 ]
Jiang, Hongnan [2 ]
Li, Ruoqi [3 ]
Song, Liying [4 ]
Chen, Ruihan [5 ]
Dong, Honglin [1 ]
机构
[1] Second Hosp Shanxi Med Univ, Dept Vasc Surg, Taiyuan 030000, Peoples R China
[2] Second Hosp Shanxi Med Univ, Dept Breast Surg, Taiyuan 030000, Peoples R China
[3] Third Hosp Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Gen Surg Dept, Taiyuan 030032, Peoples R China
[4] Shanxi Med Univ, Taiyuan 030607, Shanxi, Peoples R China
[5] Shanxi Med Univ, Clin Med Coll 1, Taiyuan 030001, Peoples R China
关键词
ARREST; CELLS;
D O I
10.1155/2022/3900636
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background. As a classic prescription in Chinese medicine treatment, Xiaochaihutang (XCHT) can improve the clinical effect and reduce serum tumor markers in patients with breast cancer (BC). However, there has not been any study to confirm the mechanism. We used bioinformatics analysis and network pharmacology to find the potential targets. Methods. The differentially expressed genes (DEGs) of BC were identified from the Cancer Genome Atlas (TCGA) dataset. Then, we utilized weighted coexpression network analysis (WGCNA) with the same dataset. The target genes of BC were obtained by comparing genes of DEGs and in significant modules of WGCNA. Drug targets of XCHT from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database were intersected with the targets of BC. The protein-protein interaction (PPI) of the drug targets was analysed by using the STRING database. We utilized the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes analysis (KEGG) enrichment analysis to identify the specific pathways and key target proteins. Receiver operator characteristic (ROC) curve was used as the verification of drug targets. Molecular docking was performed to visualize the patterns of interactions between the effective molecule and targeted protein. Results. We obtained a set of 21 target genes, which mainly encode neurotransmitter receptors or related transporters, such as OPRD1, 5-HT2A, and so on. In addition, enrichment analyses of 21 target genes showed that they were mainly concentrated in pathways related to the nervous system. Molecular docking was performed on the target gene of BC. Six active compounds can enter the active pocket of target gene, namely, naringenin, beta-sitosterol, coumestrol, nuciferine, beta-sitosterol, and protopine, thereby exerting potential therapeutic effects in BC. Conclusions. Our analysis shows that the mechanism of XCHT in the treatment of BC is mainly acting on the neurogenesis in the microenvironment of breast tumor tissue.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
    Yi, Jiaoyu
    Tian, Mengran
    Hu, Linfei
    Kang, Ning
    Ma, Weike
    Zhi, Jingtai
    Zheng, Xiangqian
    Ruan, Xianhui
    Gao, Ming
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (10)
  • [32] Potential Molecular Mechanisms of Chaihu-Shugan-San in Treatment of Breast Cancer Based on Network Pharmacology
    Xiao, Kunmin
    Li, Kexin
    Long, Sidan
    Kong, Chenfan
    Zhu, Shijie
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [33] Network Pharmacology-Based Strategy to Investigate the Mechanisms of Cibotium barometz in Treating Osteoarthritis
    Chen, Guang-Yao
    Wang, Yi-Fei
    Yu, Xin-Bo
    Liu, Xiao-Yu
    Chen, Jia-Qi
    Luo, Jing
    Tao, Qing-Wen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [34] Network Pharmacology-Based Strategy to Investigate the Mechanisms of Cibotium barometz in Treating Osteoarthritis
    Chen, Guang-Yao
    Wang, Yi-Fei
    Yu, Xin-Bo
    Liu, Xiao-Yu
    Chen, Jia-Qi
    Luo, Jing
    Tao, Qing-Wen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [35] Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
    Yu, Guohua
    Wang, Wubin
    Wang, Xu
    Xu, Meng
    Zhang, Lili
    Ding, Lei
    Guo, Rui
    Shi, Yuanyuan
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 18
  • [36] Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
    Guohua Yu
    Wubin Wang
    Xu Wang
    Meng Xu
    Lili Zhang
    Lei Ding
    Rui Guo
    Yuanyuan Shi
    BMC Complementary and Alternative Medicine, 18
  • [37] A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer
    Li, Yi
    Wang, Kexin
    Chen, Yupeng
    Cai, Jieqi
    Qin, Xuemei
    Lu, Aiping
    Guan, Daogang
    Qin, Genggeng
    Chen, Weiguo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology
    Wang, Jiyan
    Chang, Hongkai
    Su, Meng
    Zhao, Huifang
    Qiao, Yaya
    Wang, Yu
    Shang, Luqing
    Shan, Changliang
    Zhang, Shuai
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] Mechanisms of Actinidia chinensis Planch in treating colon cancer based on the integration of network pharmacology, molecular docking, and experimental verification
    Chen, Jin-Fang
    Wu, Shi-Wei
    Shi, Zi-Man
    Qu, Yan-Jie
    Ding, Min-Rui
    Hu, Bing
    HEREDITAS, 2023, 160 (01)
  • [40] Mechanisms of Actinidia chinensis Planch in treating colon cancer based on the integration of network pharmacology, molecular docking, and experimental verification
    Jin-Fang Chen
    Shi-Wei Wu
    Zi-Man Shi
    Yan-Jie Qu
    Min-Rui Ding
    Bing Hu
    Hereditas, 160